SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-014275
Filing Date
2017-07-27
Accepted
2017-07-27 16:11:13
Documents
3
Period of Report
2017-07-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rare-8k_20170727.htm 8-K 20817
2 EX-99.1 rare-ex991_6.htm EX-99.1 162261
3 GRAPHIC g201707271948080245500.jpg GRAPHIC 348834
  Complete submission text file 0001564590-17-014275.txt   664525
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 17986395
SIC: 2834 Pharmaceutical Preparations